OBJECTIVE: The interleukin 2 (IL-2) and interleukin 21 (IL-21) locus at chromosome 4q27 has been associated with several autoimmune diseases, and both genes are related to immune system functions. The aim of this study was to evaluate the role of the IL-2/IL-21 locus in systemic sclerosis (SSc). PATIENTS AND METHODS: The case control study included 4493 SSc Caucasian patients and 5856 healthy controls from eight Caucasian populations (Spain, Germany, The Netherlands, USA, Italy, Sweden, UK and Norway). Four single nucleotide polymorphisms (rs2069762, rs6822844, rs6835457 and rs907715) were genotyped using TaqMan allelic discrimination assays. RESULTS: We observed evidence of association of the rs6822844 and rs907715 variants with global SSc (pc=6.6E-4 and pc=7.2E-3, respectively). Similar statistically significant associations were observed for the limited cutaneous form of the disease. The conditional regression analysis suggested that the most likely genetic variation responsible for the association was the rs6822844 polymorphism. Consistently, the rs2069762A-rs6822844T-rs6835457G-rs907715T allelic combination showed evidence of association with SSc and limited cutaneous SSc subtype (pc=1.7E-03 and pc=8E-4, respectively). CONCLUSIONS: These results suggested that the IL-2/IL-21 locus influences the genetic susceptibility to SSc. Moreover, this study provided further support for the IL-2/IL-21 locus as a common genetic factor in autoimmune diseases.
OBJECTIVE: The interleukin 2 (IL-2) and interleukin 21 (IL-21) locus at chromosome 4q27 has been associated with several autoimmune diseases, and both genes are related to immune system functions. The aim of this study was to evaluate the role of the IL-2/IL-21 locus in systemic sclerosis (SSc). PATIENTS AND METHODS: The case control study included 4493 SSc Caucasian patients and 5856 healthy controls from eight Caucasian populations (Spain, Germany, The Netherlands, USA, Italy, Sweden, UK and Norway). Four single nucleotide polymorphisms (rs2069762, rs6822844, rs6835457 and rs907715) were genotyped using TaqMan allelic discrimination assays. RESULTS: We observed evidence of association of the rs6822844 and rs907715 variants with global SSc (pc=6.6E-4 and pc=7.2E-3, respectively). Similar statistically significant associations were observed for the limited cutaneous form of the disease. The conditional regression analysis suggested that the most likely genetic variation responsible for the association was the rs6822844 polymorphism. Consistently, the rs2069762A-rs6822844T-rs6835457G-rs907715T allelic combination showed evidence of association with SSc and limited cutaneous SSc subtype (pc=1.7E-03 and pc=8E-4, respectively). CONCLUSIONS: These results suggested that the IL-2/IL-21 locus influences the genetic susceptibility to SSc. Moreover, this study provided further support for the IL-2/IL-21 locus as a common genetic factor in autoimmune diseases.
Authors: Amit K Maiti; Xana Kim-Howard; Parvathi Viswanathan; Laura Guillén; Adriana Rojas-Villarraga; Harshal Deshmukh; Haner Direskeneli; Güher Saruhan-Direskeneli; Carlos Cañas; Gabriel J Tobön; Amr H Sawalha; Alejandra C Cherñavsky; Juan-Manuel Anaya; Swapan K Nath Journal: Arthritis Rheum Date: 2010-02
Authors: E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim Journal: J Rheumatol Date: 1988-02 Impact factor: 4.666
Authors: Luis Rodríguez-Rodríguez; Santos Castañeda; Tomás R Vázquez-Rodríguez; Inmaculada C Morado; Carmen Gómez-Vaquero; Beatriz Marí-Alfonso; José Alberto Miranda-Filloy; Javier Narvaez; Norberto Ortego-Centeno; Esther F Vicente; Ricardo Blanco; Encarnación Amigo-Diaz; Benjamín Fernández-Gutiérrez; Javier Martin; Miguel A González-Gay Journal: Clin Exp Rheumatol Date: 2011-05-11 Impact factor: 4.473
Authors: Jade E Hollis-Moffatt; Michael Chen-Xu; Ruth Topless; Nicola Dalbeth; Peter J Gow; Andrew A Harrison; John Highton; Peter B B Jones; Michael Nissen; Malcolm D Smith; Andre van Rij; Gregory T Jones; Lisa K Stamp; Tony R Merriman Journal: Arthritis Res Ther Date: 2010-06-16 Impact factor: 5.156
Authors: Helen M McGuire; Alexis Vogelzang; Natasha Hill; Malin Flodström-Tullberg; Jonathan Sprent; Cecile King Journal: Proc Natl Acad Sci U S A Date: 2009-10-30 Impact factor: 11.205
Authors: A H Sawalha; K M Kaufman; J A Kelly; A J Adler; T Aberle; J Kilpatrick; E K Wakeland; Q-Z Li; A E Wandstrat; D R Karp; J A James; J T Merrill; P Lipsky; J B Harley Journal: Ann Rheum Dis Date: 2007-08-24 Impact factor: 19.103
Authors: E A M Festen; P Goyette; R Scott; V Annese; A Zhernakova; J Lian; C Lefèbvre; S R Brant; J H Cho; M S Silverberg; K D Taylor; D J de Jong; P C Stokkers; D Mcgovern; O Palmieri; J-P Achkar; R J Xavier; M J Daly; R H Duerr; C Wijmenga; R K Weersma; J D Rioux Journal: Gut Date: 2009-02-06 Impact factor: 23.059
Authors: Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite Journal: Front Immunol Date: 2015-06-08 Impact factor: 7.561